Phase III Clinical Study Comparing the Efficacy and Safety of GZR18 Injection and Semaglutide (Wegovy®) in Adult Obese or Overweight Subjects

NCT07150975 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

420

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity/Overweight in Adult

Interventions

DRUG: GZR18
DRUG: Semaglutide(Wegovy® )

Sponsor

Gan & Lee Pharmaceuticals.